Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia
- 31 December 1981
- journal article
- research article
- Published by Elsevier BV in Leukemia Research
- Vol. 5 (6), 447-452
- https://doi.org/10.1016/0145-2126(81)90115-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemiaLeukemia Research, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaThe New England Journal of Medicine, 1979
- Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissionsBritish Journal of Cancer, 1978
- Immunotherapy of acute myeloid leukaemia.British Journal of Cancer, 1978
- Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocytic leukemia: A randomized collaborative studyMedical and Pediatric Oncology, 1978
- Towards a cure of acute granulocytic leukemia?Leukemia Research, 1977
- The Effect of Androstanes on Granulopoiesis in Vitro and in VivoBritish Journal of Haematology, 1977
- Inhibition of normal human in vitro colony forming cells by cells from leukaemic patientsBritish Journal of Cancer, 1975
- Rapid Stem Cell Differentiation Induced by 19-Nortestosterone DecanoateBritish Journal of Haematology, 1974
- Leukaemia Antigens and Immunity in ManNature, 1973